FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377293982> ?p ?o ?g. }

• W4377293982 abstract "The clinical utility and safety of sargramostim has previously been reported in cancer, acute radiation syndrome, autoimmune disease, inflammatory conditions, and Alzheimer's disease. The safety, tolerability, and mechanisms of action in Parkinson's disease (PD) during extended use has not been evaluated.As a primary goal, safety and tolerability was assessed in five PD patients treated with sargramostim (Leukine®, granulocyte-macrophage colony-stimulating factor) for 33 months. Secondary goals included numbers of CD4+ T cells and monocytes and motor functions. Hematologic, metabolic, immune, and neurological evaluations were assessed during a 5-day on, 2-day off therapeutic regimen given at 3 μg/kg. After 2 years, drug use was discontinued for 3 months. This was then followed by an additional 6 months of treatment.Sargramostim-associated adverse events included injection-site reactions, elevated total white cell counts, and bone pain. On drug, blood analyses and metabolic panels revealed no untoward side effects linked to long-term treatment. Unified Parkinson's Disease Rating Scale scores remained stable throughout the study while regulatory T cell number and function were increased. In the initial 6 months of treatment, transcriptomic and proteomic monocyte tests demonstrated autophagy and sirtuin signaling. This finding paralleled anti-inflammatory and antioxidant activities within both the adaptive and innate immune profile arms.Taken together, the data affirmed long-term safety as well as immune and anti-inflammatory responses reflecting clinical stability in PD under the sargramostim treatment. Confirmation in larger patient populations is planned in a future phase II evaluation.ClinicalTrials.gov: NCT03790670, Date of Registration: 01/02/2019, URL: https://clinicaltrials.gov/ct2/show/NCT03790670?cond=leukine+parkinson%27s&draw=2&rank=2 ." @default.
• W4377293982 created "2023-05-23" @default.
• W4377293982 creator A5009911580 @default.
• W4377293982 creator A5022556675 @default.
• W4377293982 creator A5044751219 @default.
• W4377293982 creator A5045293590 @default.
• W4377293982 creator A5048285498 @default.
• W4377293982 creator A5056325586 @default.
• W4377293982 creator A5058974129 @default.
• W4377293982 creator A5060883440 @default.
• W4377293982 date "2023-05-22" @default.
• W4377293982 modified "2023-10-02" @default.
• W4377293982 title "An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers" @default.
• W4377293982 cites W1523338791 @default.
• W4377293982 cites W1540142856 @default.
• W4377293982 cites W1546232808 @default.
• W4377293982 cites W1591327522 @default.
• W4377293982 cites W1604776255 @default.
• W4377293982 cites W1894013223 @default.
• W4377293982 cites W1980361506 @default.
• W4377293982 cites W1980747379 @default.
• W4377293982 cites W1981178584 @default.
• W4377293982 cites W1985124617 @default.
• W4377293982 cites W1992743838 @default.
• W4377293982 cites W2006470317 @default.
• W4377293982 cites W2011850477 @default.
• W4377293982 cites W2012246587 @default.
• W4377293982 cites W2021190476 @default.
• W4377293982 cites W2038325530 @default.
• W4377293982 cites W2038726784 @default.
• W4377293982 cites W2057148298 @default.
• W4377293982 cites W2063745641 @default.
• W4377293982 cites W2067671215 @default.
• W4377293982 cites W2068469528 @default.
• W4377293982 cites W2069850469 @default.
• W4377293982 cites W2072319778 @default.
• W4377293982 cites W2096705333 @default.
• W4377293982 cites W2106689521 @default.
• W4377293982 cites W2125647281 @default.
• W4377293982 cites W2131789215 @default.
• W4377293982 cites W2133759882 @default.
• W4377293982 cites W2137699813 @default.
• W4377293982 cites W2143891246 @default.
• W4377293982 cites W2155047990 @default.
• W4377293982 cites W2157535220 @default.
• W4377293982 cites W2257167523 @default.
• W4377293982 cites W2326550442 @default.
• W4377293982 cites W2339865699 @default.
• W4377293982 cites W2509656593 @default.
• W4377293982 cites W2542427033 @default.
• W4377293982 cites W2595073340 @default.
• W4377293982 cites W2595858818 @default.
• W4377293982 cites W2605252223 @default.
• W4377293982 cites W2791554250 @default.
• W4377293982 cites W2803272141 @default.
• W4377293982 cites W2804992070 @default.
• W4377293982 cites W2807589140 @default.
• W4377293982 cites W2808064789 @default.
• W4377293982 cites W2894682893 @default.
• W4377293982 cites W2900967866 @default.
• W4377293982 cites W2906403952 @default.
• W4377293982 cites W2906480617 @default.
• W4377293982 cites W2913028043 @default.
• W4377293982 cites W2921691260 @default.
• W4377293982 cites W2945170956 @default.
• W4377293982 cites W2947310842 @default.
• W4377293982 cites W2966464394 @default.
• W4377293982 cites W2971708388 @default.
• W4377293982 cites W2981142893 @default.
• W4377293982 cites W2983897971 @default.
• W4377293982 cites W2994230480 @default.
• W4377293982 cites W3001548005 @default.
• W4377293982 cites W3006139820 @default.
• W4377293982 cites W3015931662 @default.
• W4377293982 cites W3042174830 @default.
• W4377293982 cites W3042580583 @default.
• W4377293982 cites W3047366767 @default.
• W4377293982 cites W3098237024 @default.
• W4377293982 cites W3138346400 @default.
• W4377293982 cites W3149487276 @default.
• W4377293982 cites W3160583937 @default.
• W4377293982 cites W3194422279 @default.
• W4377293982 cites W3201702469 @default.
• W4377293982 cites W4242460813 @default.
• W4377293982 cites W4281701484 @default.
• W4377293982 cites W4283460436 @default.
• W4377293982 cites W4284964606 @default.
• W4377293982 cites W4285800086 @default.
• W4377293982 cites W4310558272 @default.
• W4377293982 cites W1855390974 @default.
• W4377293982 doi "https://doi.org/10.1186/s40035-023-00361-1" @default.
• W4377293982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37217980" @default.
• W4377293982 hasPublicationYear "2023" @default.
• W4377293982 type Work @default.
• W4377293982 citedByCount "3" @default.
• W4377293982 countsByYear W43772939822023 @default.
• W4377293982 crossrefType "journal-article" @default.
• W4377293982 hasAuthorship W4377293982A5009911580 @default.
• W4377293982 hasAuthorship W4377293982A5022556675 @default.
• W4377293982 hasAuthorship W4377293982A5044751219 @default.

• next